EARNEST Partners’s Quest Diagnostics DGX Stock Holding History

EARNEST Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61	Closed	-$7.43K	–	500
2023 Q3	$7.43K	Hold	61	–	–	﹤0.01%	701
2023 Q2	$8.57K	Hold	61	–	–	﹤0.01%	676
2023 Q1	$8.63K	Hold	61	–	–	﹤0.01%	655
2022 Q4	$9.54K	Hold	61	–	–	﹤0.01%	626
2022 Q3	$7K	Hold	61	–	–	﹤0.01%	672
2022 Q2	$8K	Hold	61	–	–	﹤0.01%	656
2022 Q1	$8K	Hold	61	–	–	﹤0.01%	704
2021 Q4	$11K	Hold	61	–	–	﹤0.01%	649
2021 Q3	$9K	Hold	61	–	–	﹤0.01%	676
2021 Q2	$8K	Hold	61	–	–	﹤0.01%	714
2021 Q1	$8K	Hold	61	–	–	﹤0.01%	695
2020 Q4	$7K	Hold	61	–	–	﹤0.01%	713
2020 Q3	$7K	Hold	61	–	–	﹤0.01%	648
2020 Q2	$7K	Hold	61	–	–	﹤0.01%	638
2020 Q1	$5K	Hold	61	–	–	﹤0.01%	659
2019 Q4	$7K	Hold	61	–	–	﹤0.01%	657
2019 Q3	$7K	Hold	61	–	–	﹤0.01%	643
2019 Q2	$6K	Hold	61	–	–	﹤0.01%	698
2019 Q1	$5K	Hold	61	–	–	﹤0.01%	735
2018 Q4	$5K	Hold	61	–	–	﹤0.01%	696
2018 Q3	$7K	Hold	61	–	–	﹤0.01%	657
2018 Q2	$7K	Hold	61	–	–	﹤0.01%	650
2018 Q1	$6K	Hold	61	–	–	﹤0.01%	673
2017 Q4	$6K	Buy	+61	New	+$5.78K	﹤0.01%	676
2017 Q1	–	Sell	-61	Closed	-$6K	–	415
2016 Q4	$6K	Buy	+61	New	+$5.26K	﹤0.01%	625

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EARNEST Partners's DGX Position: Q4 2023 in Review

EARNEST Partners sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 61 shares — an estimated $7.43K sold.

EARNEST Partners first reported a position in DGX in Q4 2016 and held it in 25 quarters. The position peaked at $11K in Q4 2021. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

EARNEST Partners reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 61 Quest Diagnostics shares in Q4 2023, an estimated $7.43K.
EARNEST Partners first reported a position in Quest Diagnostics in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Quest Diagnostics position peaked at $11K in Q4 2021.
827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.